Boston-based Activ Surgical designed ActivSight to provide enhanced visualization and real-time on-demand surgical insights in the operating room. The easy-to-adapt model seamlessly attaches to laparoscopic and robotic systems. Activ Surgical received CE mark approval for ActivSight in December 2022. The FDA cleared the technology in April 2021. The company aims to transform the surgical experience using emerging technologies and data.

Learn more about what comes next. In 2016, Dr. Peter Kim, founder of Activ Surgical, a digital surgery company, demonstrated a proof of concept of fully autonomous robotic surgery on soft tissue, suturing, or stitching up a wound. Since then, Activ Surgical has been working on harnessing machine learning, augmented reality, and other advanced technologies to develop new ways of collaborating with surgeons. "We want to keep surgeons in the loop, to give them more data than they ever had before," says CEO Todd Usen. Usen likens Activ Surgical's work in surgery to crossing goalposts in the drive toward autonomous driving: It might take a while to get there, but the industry is ramping up systematically.